

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 6.05543237 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 5.74758228 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.74758228 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.63844917 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.63844917 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.42792834 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.29016856 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.29016856 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.29016856 |
| 10 | NADH metabolic process (GO:0006734) | 5.25911229 |
| 11 | proline metabolic process (GO:0006560) | 4.99696528 |
| 12 | proline biosynthetic process (GO:0006561) | 4.97856150 |
| 13 | kynurenine metabolic process (GO:0070189) | 4.97782838 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.87269507 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.84924390 |
| 16 | omega-hydroxylase P450 pathway (GO:0097267) | 4.75210679 |
| 17 | glyoxylate metabolic process (GO:0046487) | 4.70927262 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.53749083 |
| 19 | drug metabolic process (GO:0017144) | 4.50264965 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.48896887 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.30244874 |
| 22 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.29943325 |
| 23 | cellular glucuronidation (GO:0052695) | 4.20159879 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 4.19084510 |
| 25 | ethanol oxidation (GO:0006069) | 4.15865438 |
| 26 | bile acid metabolic process (GO:0008206) | 4.11487576 |
| 27 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.04940852 |
| 28 | glucuronate metabolic process (GO:0019585) | 4.00038214 |
| 29 | uronic acid metabolic process (GO:0006063) | 4.00038214 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 3.99490899 |
| 31 | acylglycerol homeostasis (GO:0055090) | 3.98254943 |
| 32 | triglyceride homeostasis (GO:0070328) | 3.98254943 |
| 33 | lysine catabolic process (GO:0006554) | 3.97323854 |
| 34 | lysine metabolic process (GO:0006553) | 3.97323854 |
| 35 | cysteine metabolic process (GO:0006534) | 3.96205372 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 3.95086238 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.94776449 |
| 38 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.93634557 |
| 39 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.93634557 |
| 40 | ethanol metabolic process (GO:0006067) | 3.84974834 |
| 41 | glutamate metabolic process (GO:0006536) | 3.84071444 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 3.82644587 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79049905 |
| 44 | urea cycle (GO:0000050) | 3.74121928 |
| 45 | urea metabolic process (GO:0019627) | 3.74121928 |
| 46 | heme transport (GO:0015886) | 3.70175371 |
| 47 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.69563544 |
| 48 | cholesterol efflux (GO:0033344) | 3.68647576 |
| 49 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68584686 |
| 50 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.67756771 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 3.66884626 |
| 52 | cellular amino acid catabolic process (GO:0009063) | 3.66826578 |
| 53 | regulation of cholesterol homeostasis (GO:2000188) | 3.65792041 |
| 54 | glycine metabolic process (GO:0006544) | 3.65379758 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 3.65056116 |
| 56 | drug catabolic process (GO:0042737) | 3.64772023 |
| 57 | protein carboxylation (GO:0018214) | 3.63900780 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.63900780 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 3.61287708 |
| 60 | amine catabolic process (GO:0009310) | 3.61287708 |
| 61 | fructose metabolic process (GO:0006000) | 3.60583954 |
| 62 | regulation of protein activation cascade (GO:2000257) | 3.60223288 |
| 63 | cytolysis (GO:0019835) | 3.59375462 |
| 64 | phospholipid efflux (GO:0033700) | 3.59207371 |
| 65 | drug transmembrane transport (GO:0006855) | 3.56857625 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 3.56389231 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 3.56389231 |
| 68 | macromolecular complex remodeling (GO:0034367) | 3.56389231 |
| 69 | amino-acid betaine metabolic process (GO:0006577) | 3.56031391 |
| 70 | coenzyme catabolic process (GO:0009109) | 3.55704792 |
| 71 | transcription from mitochondrial promoter (GO:0006390) | 3.54741583 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 3.54326609 |
| 73 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.53792836 |
| 74 | complement activation, alternative pathway (GO:0006957) | 3.53401140 |
| 75 | reverse cholesterol transport (GO:0043691) | 3.53011158 |
| 76 | urate metabolic process (GO:0046415) | 3.50344159 |
| 77 | primary alcohol catabolic process (GO:0034310) | 3.49829162 |
| 78 | angiotensin maturation (GO:0002003) | 3.49698767 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.48627828 |
| 80 | regulation of cholesterol metabolic process (GO:0090181) | 3.45969631 |
| 81 | regulation of fibrinolysis (GO:0051917) | 3.45465399 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 3.44889269 |
| 83 | negative regulation of sterol transport (GO:0032372) | 3.44889269 |
| 84 | intestinal cholesterol absorption (GO:0030299) | 3.44294830 |
| 85 | homocysteine metabolic process (GO:0050667) | 3.39509584 |
| 86 | polyketide metabolic process (GO:0030638) | 3.38751963 |
| 87 | doxorubicin metabolic process (GO:0044598) | 3.38751963 |
| 88 | daunorubicin metabolic process (GO:0044597) | 3.38751963 |
| 89 | oxaloacetate metabolic process (GO:0006107) | 3.38511165 |
| 90 | NAD biosynthetic process (GO:0009435) | 3.38277481 |
| 91 | acetyl-CoA metabolic process (GO:0006084) | 3.37310206 |
| 92 | Golgi transport vesicle coating (GO:0048200) | 3.33564961 |
| 93 | COPI coating of Golgi vesicle (GO:0048205) | 3.33564961 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 3.32304576 |
| 95 | regulation of complement activation (GO:0030449) | 3.31225369 |
| 96 | indole-containing compound metabolic process (GO:0042430) | 3.30345603 |
| 97 | 2-oxoglutarate metabolic process (GO:0006103) | 3.26864598 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.26634561 |
| 99 | hormone catabolic process (GO:0042447) | 3.25551459 |
| 100 | organic acid catabolic process (GO:0016054) | 3.21953797 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.21953797 |
| 102 | exogenous drug catabolic process (GO:0042738) | 3.20368507 |
| 103 | cellular modified amino acid catabolic process (GO:0042219) | 3.17353121 |
| 104 | plasma lipoprotein particle assembly (GO:0034377) | 3.17295007 |
| 105 | NAD metabolic process (GO:0019674) | 3.16183104 |
| 106 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.11514353 |
| 107 | regulation of triglyceride catabolic process (GO:0010896) | 3.10511534 |
| 108 | tyrosine metabolic process (GO:0006570) | 3.09532372 |
| 109 | glycosphingolipid catabolic process (GO:0046479) | 3.09505552 |
| 110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.08938993 |
| 111 | bile acid and bile salt transport (GO:0015721) | 3.07728750 |
| 112 | tricarboxylic acid metabolic process (GO:0072350) | 3.07077297 |
| 113 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.06777617 |
| 114 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.06777617 |
| 115 | very long-chain fatty acid metabolic process (GO:0000038) | 3.06658062 |
| 116 | ketone body metabolic process (GO:1902224) | 3.06563937 |
| 117 | biotin metabolic process (GO:0006768) | 3.06194726 |
| 118 | low-density lipoprotein particle remodeling (GO:0034374) | 3.05062469 |
| 119 | aspartate family amino acid catabolic process (GO:0009068) | 3.03573860 |
| 120 | fibrinolysis (GO:0042730) | 3.02793171 |
| 121 | glucose 6-phosphate metabolic process (GO:0051156) | 3.02568190 |
| 122 | neuromuscular process controlling posture (GO:0050884) | 3.00518114 |
| 123 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.99567041 |
| 124 | phenylpropanoid metabolic process (GO:0009698) | 2.99237881 |
| 125 | fatty acid beta-oxidation (GO:0006635) | 2.98045691 |
| 126 | serine family amino acid biosynthetic process (GO:0009070) | 2.97815245 |
| 127 | DNA unwinding involved in DNA replication (GO:0006268) | 2.97147486 |
| 128 | protein retention in ER lumen (GO:0006621) | 2.97129885 |
| 129 | alkaloid metabolic process (GO:0009820) | 2.96892759 |
| 130 | monocarboxylic acid catabolic process (GO:0072329) | 2.96773148 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.96257944 |
| 132 | blood coagulation, intrinsic pathway (GO:0007597) | 2.95797569 |
| 133 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.94806601 |
| 134 | complement activation, classical pathway (GO:0006958) | 2.94214209 |
| 135 | intestinal absorption (GO:0050892) | 2.94138999 |
| 136 | response to mercury ion (GO:0046689) | 2.94072713 |
| 137 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.93952916 |
| 138 | flavonoid metabolic process (GO:0009812) | 2.93263237 |
| 139 | dicarboxylic acid catabolic process (GO:0043649) | 2.92531302 |
| 140 | serine family amino acid metabolic process (GO:0009069) | 2.91410171 |
| 141 | regulation of protein homooligomerization (GO:0032462) | 2.90028159 |
| 142 | fatty acid catabolic process (GO:0009062) | 2.89574670 |
| 143 | pinocytosis (GO:0006907) | 2.89562474 |
| 144 | gluconeogenesis (GO:0006094) | 2.84960803 |
| 145 | glycolipid catabolic process (GO:0019377) | 2.84394965 |
| 146 | positive regulation of lipid catabolic process (GO:0050996) | 2.83615256 |
| 147 | glycoside metabolic process (GO:0016137) | 2.81166551 |
| 148 | complement activation (GO:0006956) | 2.79178953 |
| 149 | monosaccharide biosynthetic process (GO:0046364) | 2.76680181 |
| 150 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.76554991 |
| 151 | drug transport (GO:0015893) | 2.76180259 |
| 152 | hexose biosynthetic process (GO:0019319) | 2.72293134 |
| 153 | pentose-phosphate shunt (GO:0006098) | 2.72028509 |
| 154 | acute-phase response (GO:0006953) | 2.71689692 |
| 155 | folic acid metabolic process (GO:0046655) | 2.70521103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.31480133 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.87676863 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.80866581 |
| 4 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.34648975 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.20550384 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.09736941 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.31456621 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.18501266 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.15408537 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.88774145 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.54768809 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.53865157 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36002027 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27162831 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.15853856 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.09321195 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.08038644 |
| 18 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.07189982 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.06774489 |
| 20 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.06183498 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88329175 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86492460 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82676540 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.78983399 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76733264 |
| 26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.74941751 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.70327330 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.67653974 |
| 29 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.66989980 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62204697 |
| 31 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62001097 |
| 32 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58276231 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56728273 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54733813 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.50951613 |
| 36 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45763193 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43647004 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.43268585 |
| 39 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43110337 |
| 40 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.40129797 |
| 41 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37583546 |
| 42 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37289962 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35723933 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35311946 |
| 45 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33607879 |
| 46 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.32789611 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30101983 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29349052 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29260498 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28550426 |
| 51 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28150654 |
| 52 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.28117012 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27695091 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26606362 |
| 55 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26308612 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26305105 |
| 57 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25575482 |
| 58 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.23712584 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23621884 |
| 60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20715156 |
| 61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20710589 |
| 62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20562094 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18865873 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18387687 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17168426 |
| 66 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16702462 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15329633 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15260062 |
| 69 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15234259 |
| 70 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14886052 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14653768 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13009518 |
| 73 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12904224 |
| 74 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11637866 |
| 75 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.11474556 |
| 76 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.11276875 |
| 77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10402334 |
| 78 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10390137 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10070710 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08528682 |
| 81 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08133100 |
| 82 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.07989745 |
| 83 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07510986 |
| 84 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07440283 |
| 85 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07326306 |
| 86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06671500 |
| 87 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06626361 |
| 88 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06263541 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06243104 |
| 90 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05955642 |
| 91 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.05163114 |
| 92 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02929152 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02607318 |
| 94 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02321211 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02278792 |
| 96 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.02177533 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99543868 |
| 98 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97703524 |
| 99 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97436852 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97098593 |
| 101 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97035085 |
| 102 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96261801 |
| 103 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.95738453 |
| 104 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95681902 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94598007 |
| 106 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.94164356 |
| 107 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94158185 |
| 108 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94077505 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93562577 |
| 110 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92760843 |
| 111 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91232794 |
| 112 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90744941 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90296815 |
| 114 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89867107 |
| 115 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89012718 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86742161 |
| 117 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.86502868 |
| 118 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86268104 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.86044299 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85354358 |
| 121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84767001 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83860844 |
| 123 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82638812 |
| 124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.81506754 |
| 125 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81255822 |
| 126 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.80783817 |
| 127 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.75927564 |
| 128 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75160542 |
| 129 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.74300249 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.73762608 |
| 131 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72107523 |
| 132 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.70440704 |
| 133 | * FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.69922579 |
| 134 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.69761229 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69476561 |
| 136 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.69397304 |
| 137 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69018374 |
| 138 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.68993160 |
| 139 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.67846837 |
| 140 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.67685430 |
| 141 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.67614423 |
| 142 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.65601772 |
| 143 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65169169 |
| 144 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.64228459 |
| 145 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64153596 |
| 146 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.63133716 |
| 147 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.62152380 |
| 148 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.61467543 |
| 149 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.61467543 |
| 150 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.61238141 |
| 151 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.60266049 |
| 152 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.60254820 |
| 153 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.59696674 |
| 154 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.59492992 |
| 155 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.59432981 |
| 156 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.59044220 |
| 157 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.58539195 |
| 158 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.58256128 |
| 159 | AR_25329375_ChIP-Seq_VCAP_Human | 0.57949330 |
| 160 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.57328412 |
| 161 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.56583914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.72465226 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.76994681 |
| 3 | MP0005360_urolithiasis | 5.73231256 |
| 4 | MP0005365_abnormal_bile_salt | 5.71826978 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.75017718 |
| 6 | MP0005451_abnormal_body_composition | 3.70740237 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 2.94494872 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.81505346 |
| 9 | MP0003252_abnormal_bile_duct | 2.72359632 |
| 10 | MP0003195_calcinosis | 2.66667364 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.63790466 |
| 12 | MP0005332_abnormal_amino_acid | 2.61987085 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.47555652 |
| 14 | MP0005083_abnormal_biliary_tract | 2.46477977 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.33487434 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.32904264 |
| 17 | MP0009840_abnormal_foam_cell | 2.23414282 |
| 18 | MP0002822_catalepsy | 2.16923671 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.01322201 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.89726189 |
| 21 | MP0005409_darkened_coat_color | 1.88729572 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.87708950 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.85350179 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.73622285 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.69771948 |
| 26 | MP0001764_abnormal_homeostasis | 1.69512636 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.59984702 |
| 28 | MP0009046_muscle_twitch | 1.58634355 |
| 29 | MP0000609_abnormal_liver_physiology | 1.56882157 |
| 30 | MP0005666_abnormal_adipose_tissue | 1.52091335 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.50264309 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.48742529 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48671207 |
| 34 | MP0003868_abnormal_feces_composition | 1.47760516 |
| 35 | MP0001849_ear_inflammation | 1.46902513 |
| 36 | MP0002009_preneoplasia | 1.44184994 |
| 37 | MP0003635_abnormal_synaptic_transmissio | 1.43812267 |
| 38 | MP0002064_seizures | 1.41043794 |
| 39 | MP0008260_abnormal_autophagy | 1.40123261 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.37975274 |
| 41 | MP0003880_abnormal_central_pattern | 1.37161209 |
| 42 | MP0009745_abnormal_behavioral_response | 1.34445763 |
| 43 | MP0004043_abnormal_pH_regulation | 1.32361341 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.27995442 |
| 45 | MP0009278_abnormal_bone_marrow | 1.23590152 |
| 46 | MP0005535_abnormal_body_temperature | 1.23328841 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.22243365 |
| 48 | MP0002796_impaired_skin_barrier | 1.20917896 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.20748300 |
| 50 | MP0004142_abnormal_muscle_tone | 1.19951283 |
| 51 | MP0003329_amyloid_beta_deposits | 1.18640435 |
| 52 | MP0005647_abnormal_sex_gland | 1.15933193 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.15446215 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.14980005 |
| 55 | MP0001968_abnormal_touch/_nociception | 1.14700760 |
| 56 | MP0009697_abnormal_copulation | 1.12961293 |
| 57 | MP0004858_abnormal_nervous_system | 1.12681879 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.12251975 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 1.10641731 |
| 60 | MP0002736_abnormal_nociception_after | 1.10611059 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.09846286 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.09741773 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.09055880 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.08895617 |
| 65 | MP0005501_abnormal_skin_physiology | 1.06192397 |
| 66 | MP0002272_abnormal_nervous_system | 1.05900004 |
| 67 | MP0000678_abnormal_parathyroid_gland | 1.05659896 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.02261123 |
| 69 | MP0000639_abnormal_adrenal_gland | 1.00769241 |
| 70 | MP0003879_abnormal_hair_cell | 1.00416617 |
| 71 | MP0000490_abnormal_crypts_of | 1.00340985 |
| 72 | MP0005375_adipose_tissue_phenotype | 0.99922814 |
| 73 | MP0005166_decreased_susceptibility_to | 0.94461620 |
| 74 | MP0004233_abnormal_muscle_weight | 0.94328697 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 0.94314309 |
| 76 | MP0002733_abnormal_thermal_nociception | 0.92962018 |
| 77 | MP0002067_abnormal_sensory_capabilities | 0.91971030 |
| 78 | MP0008874_decreased_physiological_sensi | 0.91039543 |
| 79 | MP0001984_abnormal_olfaction | 0.90597181 |
| 80 | MP0002735_abnormal_chemical_nociception | 0.90579308 |
| 81 | MP0000604_amyloidosis | 0.90056811 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.89884518 |
| 83 | MP0005464_abnormal_platelet_physiology | 0.89717490 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.89515350 |
| 85 | MP0005448_abnormal_energy_balance | 0.88682933 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.88163617 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 0.87124223 |
| 88 | MP0003283_abnormal_digestive_organ | 0.86479485 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.85518449 |
| 90 | MP0003953_abnormal_hormone_level | 0.85459839 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.84529117 |
| 92 | MP0004130_abnormal_muscle_cell | 0.84505612 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.83815778 |
| 94 | MP0002098_abnormal_vibrissa_morphology | 0.83473136 |
| 95 | MP0003633_abnormal_nervous_system | 0.83205336 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.82244826 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.81949949 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.80963949 |
| 99 | MP0003866_abnormal_defecation | 0.80920802 |
| 100 | MP0000467_abnormal_esophagus_morphology | 0.80501076 |
| 101 | MP0001440_abnormal_grooming_behavior | 0.80106110 |
| 102 | MP0000747_muscle_weakness | 0.79645135 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 0.78818043 |
| 104 | MP0000477_abnormal_intestine_morphology | 0.77524025 |
| 105 | MP0005266_abnormal_metabolism | 0.76259568 |
| 106 | MP0009764_decreased_sensitivity_to | 0.75449102 |
| 107 | MP0001970_abnormal_pain_threshold | 0.74350372 |
| 108 | MP0003638_abnormal_response/metabolism_ | 0.73881618 |
| 109 | MP0003693_abnormal_embryo_hatching | 0.72626947 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.72263346 |
| 111 | MP0000598_abnormal_liver_morphology | 0.70832006 |
| 112 | MP0002971_abnormal_brown_adipose | 0.69760070 |
| 113 | MP0005376_homeostasis/metabolism_phenot | 0.69327801 |
| 114 | MP0000579_abnormal_nail_morphology | 0.68312021 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.68208078 |
| 116 | MP0008872_abnormal_physiological_respon | 0.68073525 |
| 117 | MP0009379_abnormal_foot_pigmentation | 0.67750032 |
| 118 | MP0005670_abnormal_white_adipose | 0.67731009 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.67438648 |
| 120 | MP0004270_analgesia | 0.67239551 |
| 121 | MP0005386_behavior/neurological_phenoty | 0.67201199 |
| 122 | MP0004924_abnormal_behavior | 0.67201199 |
| 123 | MP0005171_absent_coat_pigmentation | 0.66313737 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.66301895 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.66301895 |
| 126 | MP0000566_synostosis | 0.65860674 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.65761715 |
| 128 | MP0004947_skin_inflammation | 0.65695680 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.65527379 |
| 130 | MP0005058_abnormal_lysosome_morphology | 0.65135253 |
| 131 | MP0001881_abnormal_mammary_gland | 0.65111140 |
| 132 | MP0003075_altered_response_to | 0.64279946 |
| 133 | MP0006276_abnormal_autonomic_nervous | 0.63917129 |
| 134 | MP0003690_abnormal_glial_cell | 0.63457938 |
| 135 | MP0009333_abnormal_splenocyte_physiolog | 0.63395403 |
| 136 | MP0010094_abnormal_chromosome_stability | 0.63350483 |
| 137 | MP0001486_abnormal_startle_reflex | 0.62436160 |
| 138 | MP0008469_abnormal_protein_level | 0.62099336 |
| 139 | MP0001756_abnormal_urination | 0.61774576 |
| 140 | MP0001664_abnormal_digestion | 0.61740844 |
| 141 | MP0000858_altered_metastatic_potential | 0.60778307 |
| 142 | MP0005379_endocrine/exocrine_gland_phen | 0.60319755 |
| 143 | MP0010386_abnormal_urinary_bladder | 0.60086584 |
| 144 | MP0005334_abnormal_fat_pad | 0.59353431 |
| 145 | MP0002970_abnormal_white_adipose | 0.59010864 |
| 146 | MP0008569_lethality_at_weaning | 0.58253639 |
| 147 | MP0002928_abnormal_bile_duct | 0.58217354 |
| 148 | MP0005551_abnormal_eye_electrophysiolog | 0.58193908 |
| 149 | MP0000462_abnormal_digestive_system | 0.56731043 |
| 150 | MP0003011_delayed_dark_adaptation | 0.56531989 |
| 151 | MP0001661_extended_life_span | 0.55307337 |
| 152 | MP0005330_cardiomyopathy | 0.55090263 |
| 153 | MP0009931_abnormal_skin_appearance | 0.54451656 |
| 154 | MP0002132_abnormal_respiratory_system | 0.54358254 |
| 155 | MP0002136_abnormal_kidney_physiology | 0.54264767 |
| 156 | MP0003436_decreased_susceptibility_to | 0.54172198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.67535861 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.96217542 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 4.75416955 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 4.40957658 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.32852645 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.19317240 |
| 7 | Ketosis (HP:0001946) | 4.11248567 |
| 8 | Ketoacidosis (HP:0001993) | 4.05756781 |
| 9 | Xanthomatosis (HP:0000991) | 4.05714274 |
| 10 | Hyperglycinemia (HP:0002154) | 4.01852218 |
| 11 | Gout (HP:0001997) | 3.86069556 |
| 12 | Hyperglycinuria (HP:0003108) | 3.81471196 |
| 13 | Hyperammonemia (HP:0001987) | 3.69050748 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.59004196 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 3.43445122 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.43405902 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.43405902 |
| 18 | Complement deficiency (HP:0004431) | 3.36012574 |
| 19 | Hypochromic microcytic anemia (HP:0004840) | 3.34646057 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23648844 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.20307282 |
| 22 | Focal motor seizures (HP:0011153) | 3.16735006 |
| 23 | Fat malabsorption (HP:0002630) | 3.15687915 |
| 24 | Joint hemorrhage (HP:0005261) | 3.13646500 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.12290253 |
| 26 | Glomerulonephritis (HP:0000099) | 3.10437767 |
| 27 | Status epilepticus (HP:0002133) | 2.96513168 |
| 28 | Abnormality of purine metabolism (HP:0004352) | 2.96307976 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 2.95067864 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.94832024 |
| 31 | Hemorrhage of the eye (HP:0011885) | 2.84942982 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.82388403 |
| 33 | Hypoglycemic seizures (HP:0002173) | 2.75808075 |
| 34 | Epidermoid cyst (HP:0200040) | 2.75723221 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.75383769 |
| 36 | Hyperventilation (HP:0002883) | 2.73107360 |
| 37 | Hyperbilirubinemia (HP:0002904) | 2.69070549 |
| 38 | Febrile seizures (HP:0002373) | 2.69042152 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.67669611 |
| 40 | Delayed CNS myelination (HP:0002188) | 2.67382957 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.66771894 |
| 42 | Lethargy (HP:0001254) | 2.65831425 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.63643167 |
| 44 | Metabolic acidosis (HP:0001942) | 2.59679085 |
| 45 | Ragged-red muscle fibers (HP:0003200) | 2.57439142 |
| 46 | Abnormality of methionine metabolism (HP:0010901) | 2.53471506 |
| 47 | Acute hepatic failure (HP:0006554) | 2.52024174 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.49886431 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.49613970 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.48516636 |
| 51 | Abnormality of the Achilles tendon (HP:0005109) | 2.48262815 |
| 52 | Lower limb hyperreflexia (HP:0002395) | 2.47759263 |
| 53 | Rhabdomyolysis (HP:0003201) | 2.45751666 |
| 54 | Growth hormone excess (HP:0000845) | 2.43893717 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.43642133 |
| 56 | Sensorimotor neuropathy (HP:0007141) | 2.40691235 |
| 57 | Hypoalphalipoproteinemia (HP:0003233) | 2.40625170 |
| 58 | Irritability (HP:0000737) | 2.40287985 |
| 59 | Spontaneous abortion (HP:0005268) | 2.38830085 |
| 60 | Cerebral palsy (HP:0100021) | 2.38570539 |
| 61 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.38376278 |
| 62 | Atonic seizures (HP:0010819) | 2.37808436 |
| 63 | Myokymia (HP:0002411) | 2.37411524 |
| 64 | Steatorrhea (HP:0002570) | 2.36948410 |
| 65 | Vertebral compression fractures (HP:0002953) | 2.31942431 |
| 66 | Abnormality of glycolysis (HP:0004366) | 2.31608989 |
| 67 | Purpura (HP:0000979) | 2.30310997 |
| 68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.29913324 |
| 69 | Epileptic encephalopathy (HP:0200134) | 2.29558046 |
| 70 | Opisthotonus (HP:0002179) | 2.29253837 |
| 71 | Reticulocytosis (HP:0001923) | 2.28451044 |
| 72 | Late onset (HP:0003584) | 2.28360362 |
| 73 | Increased IgM level (HP:0003496) | 2.27575508 |
| 74 | Alkalosis (HP:0001948) | 2.27435391 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26465850 |
| 76 | Increased purine levels (HP:0004368) | 2.22201153 |
| 77 | Hyperuricemia (HP:0002149) | 2.22201153 |
| 78 | Exercise-induced myalgia (HP:0003738) | 2.21395791 |
| 79 | Symptomatic seizures (HP:0011145) | 2.21335032 |
| 80 | Nephritis (HP:0000123) | 2.21152752 |
| 81 | Abnormality of complement system (HP:0005339) | 2.19977913 |
| 82 | Turricephaly (HP:0000262) | 2.18885296 |
| 83 | Achilles tendon contracture (HP:0001771) | 2.18069173 |
| 84 | Increased serum pyruvate (HP:0003542) | 2.17674640 |
| 85 | J-shaped sella turcica (HP:0002680) | 2.16412250 |
| 86 | Abdominal distention (HP:0003270) | 2.16165512 |
| 87 | Thin bony cortex (HP:0002753) | 2.16154668 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16074129 |
| 89 | Neonatal onset (HP:0003623) | 2.16048281 |
| 90 | Cholecystitis (HP:0001082) | 2.15932189 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.15932189 |
| 92 | Cerebral edema (HP:0002181) | 2.14395991 |
| 93 | Vomiting (HP:0002013) | 2.11454596 |
| 94 | Spastic paraparesis (HP:0002313) | 2.10673817 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10032986 |
| 96 | Mucopolysacchariduria (HP:0008155) | 2.10032986 |
| 97 | Absence seizures (HP:0002121) | 2.08750428 |
| 98 | Pustule (HP:0200039) | 2.08118740 |
| 99 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.07699728 |
| 100 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04895301 |
| 101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04895301 |
| 102 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04895301 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04623291 |
| 104 | Dicarboxylic aciduria (HP:0003215) | 2.04623291 |
| 105 | Elevated alkaline phosphatase (HP:0003155) | 2.04471360 |
| 106 | Dysostosis multiplex (HP:0000943) | 2.03853332 |
| 107 | Microvesicular hepatic steatosis (HP:0001414) | 2.03065030 |
| 108 | Stroke (HP:0001297) | 2.01948037 |
| 109 | Hypercholesterolemia (HP:0003124) | 2.01851211 |
| 110 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.01744832 |
| 111 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.01744832 |
| 112 | Hyperparathyroidism (HP:0000843) | 2.01609256 |
| 113 | Paraparesis (HP:0002385) | 1.98456932 |
| 114 | Wide cranial sutures (HP:0010537) | 1.98210284 |
| 115 | Amyloidosis (HP:0011034) | 1.97492538 |
| 116 | Progressive muscle weakness (HP:0003323) | 1.96815377 |
| 117 | Pili torti (HP:0003777) | 1.96355106 |
| 118 | Malnutrition (HP:0004395) | 1.94425013 |
| 119 | Menorrhagia (HP:0000132) | 1.94025038 |
| 120 | Back pain (HP:0003418) | 1.93970274 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93607284 |
| 122 | Polygenic inheritance (HP:0010982) | 1.93600196 |
| 123 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92821719 |
| 124 | Flat acetabular roof (HP:0003180) | 1.92296487 |
| 125 | Cholelithiasis (HP:0001081) | 1.92211565 |
| 126 | Alopecia of scalp (HP:0002293) | 1.90715877 |
| 127 | Visual hallucinations (HP:0002367) | 1.90283201 |
| 128 | Increased serum ferritin (HP:0003281) | 1.89140886 |
| 129 | Annular pancreas (HP:0001734) | 1.88941191 |
| 130 | Seborrheic dermatitis (HP:0001051) | 1.87933257 |
| 131 | Abnormality of the lower motor neuron (HP:0002366) | 1.87150143 |
| 132 | Neurofibrillary tangles (HP:0002185) | 1.86609618 |
| 133 | Distal lower limb muscle weakness (HP:0009053) | 1.85802879 |
| 134 | Axonal loss (HP:0003447) | 1.85672714 |
| 135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84726667 |
| 136 | Abnormal cartilage morphology (HP:0002763) | 1.84569407 |
| 137 | Hyperacusis (HP:0010780) | 1.84326825 |
| 138 | Abnormality of proline metabolism (HP:0010907) | 1.82130344 |
| 139 | Hydroxyprolinuria (HP:0003080) | 1.82130344 |
| 140 | Hypophosphatemia (HP:0002148) | 1.81105559 |
| 141 | Dysautonomia (HP:0002459) | 1.81050785 |
| 142 | Mitral stenosis (HP:0001718) | 1.81010446 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.79739499 |
| 144 | Cellulitis (HP:0100658) | 1.79337588 |
| 145 | Myoglobinuria (HP:0002913) | 1.78931144 |
| 146 | Poor suck (HP:0002033) | 1.78505147 |
| 147 | Abnormality of the periventricular white matter (HP:0002518) | 1.77343415 |
| 148 | Myopathic facies (HP:0002058) | 1.77257313 |
| 149 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76608918 |
| 150 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76608918 |
| 151 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76608918 |
| 152 | Myocardial infarction (HP:0001658) | 1.76288305 |
| 153 | Hypotension (HP:0002615) | 1.75993939 |
| 154 | Neuronal loss in central nervous system (HP:0002529) | 1.75273579 |
| 155 | Widely patent fontanelles and sutures (HP:0004492) | 1.74794631 |
| 156 | Bone pain (HP:0002653) | 1.74763043 |
| 157 | Dialeptic seizures (HP:0011146) | 1.73635003 |
| 158 | Systemic lupus erythematosus (HP:0002725) | 1.73030557 |
| 159 | Oligomenorrhea (HP:0000876) | 1.72632440 |
| 160 | Epileptiform EEG discharges (HP:0011182) | 1.72628537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.61745073 |
| 2 | MAPK15 | 3.85316145 |
| 3 | PINK1 | 3.78609953 |
| 4 | RIPK1 | 3.61912206 |
| 5 | BCKDK | 3.11390213 |
| 6 | DAPK1 | 3.04866550 |
| 7 | SCYL2 | 2.91228161 |
| 8 | TESK2 | 2.89246175 |
| 9 | MAP3K6 | 2.84191627 |
| 10 | NTRK3 | 2.79661043 |
| 11 | EEF2K | 2.70172300 |
| 12 | MAP3K11 | 2.65316692 |
| 13 | ICK | 2.60854430 |
| 14 | IRAK3 | 2.56401608 |
| 15 | SIK3 | 2.52576339 |
| 16 | EPHA4 | 2.50881381 |
| 17 | SMG1 | 2.50592740 |
| 18 | MAP2K7 | 2.34678898 |
| 19 | NME2 | 2.33472232 |
| 20 | TESK1 | 2.22351940 |
| 21 | DAPK2 | 2.13272692 |
| 22 | INSRR | 2.06068718 |
| 23 | MAP2K4 | 2.04408447 |
| 24 | STK16 | 2.04352661 |
| 25 | MAP3K12 | 1.98342966 |
| 26 | EPHA2 | 1.97390304 |
| 27 | AKT3 | 1.95174341 |
| 28 | MST1R | 1.89048299 |
| 29 | DDR2 | 1.81109507 |
| 30 | MATK | 1.75093210 |
| 31 | MAP3K4 | 1.74158903 |
| 32 | CASK | 1.64259340 |
| 33 | FGFR4 | 1.62736255 |
| 34 | PKN2 | 1.59184936 |
| 35 | PRPF4B | 1.55970236 |
| 36 | SIK1 | 1.52159178 |
| 37 | FGR | 1.47481726 |
| 38 | KSR2 | 1.31117581 |
| 39 | YES1 | 1.30727469 |
| 40 | MAP3K9 | 1.26008169 |
| 41 | STK38 | 1.23685503 |
| 42 | MINK1 | 1.22601156 |
| 43 | DYRK1B | 1.22517451 |
| 44 | MAP2K2 | 1.22508719 |
| 45 | MAP3K10 | 1.22063946 |
| 46 | PDPK1 | 1.19622012 |
| 47 | MAPK11 | 1.18292356 |
| 48 | PRKD2 | 1.16150884 |
| 49 | UHMK1 | 1.12978595 |
| 50 | BRAF | 1.09322979 |
| 51 | MAP2K3 | 1.07952184 |
| 52 | RIPK4 | 1.06739020 |
| 53 | PDK2 | 1.06040471 |
| 54 | TYRO3 | 1.05883968 |
| 55 | VRK2 | 1.04526712 |
| 56 | CSK | 1.04283071 |
| 57 | SIK2 | 1.04009130 |
| 58 | ERN1 | 1.03612558 |
| 59 | KDR | 1.03498528 |
| 60 | CAMK2G | 1.02134981 |
| 61 | TBK1 | 0.99502571 |
| 62 | MAPKAPK3 | 0.99309264 |
| 63 | PTK6 | 0.96350774 |
| 64 | PHKG2 | 0.95592493 |
| 65 | PHKG1 | 0.95592493 |
| 66 | TAOK2 | 0.95001790 |
| 67 | PRKD3 | 0.94941466 |
| 68 | TNK2 | 0.94183212 |
| 69 | PRKCG | 0.94088949 |
| 70 | BMX | 0.91516068 |
| 71 | LMTK2 | 0.89117368 |
| 72 | IRAK2 | 0.85056615 |
| 73 | MAP3K13 | 0.84607636 |
| 74 | CDK12 | 0.83984494 |
| 75 | CDK19 | 0.83280100 |
| 76 | PRKG2 | 0.81142368 |
| 77 | PRKAA1 | 0.81101348 |
| 78 | SGK2 | 0.80508979 |
| 79 | ABL2 | 0.78031606 |
| 80 | PAK4 | 0.77988650 |
| 81 | CDK7 | 0.77205685 |
| 82 | CAMK2B | 0.76789723 |
| 83 | RPS6KB2 | 0.74582329 |
| 84 | CSF1R | 0.72484485 |
| 85 | CDK4 | 0.72210052 |
| 86 | LRRK2 | 0.72027432 |
| 87 | PDGFRA | 0.71291378 |
| 88 | PDK1 | 0.70663217 |
| 89 | ALK | 0.70329498 |
| 90 | CAMKK1 | 0.70270890 |
| 91 | CAMK2A | 0.70111566 |
| 92 | PRKCZ | 0.67585424 |
| 93 | PIM2 | 0.67069978 |
| 94 | NTRK2 | 0.66526383 |
| 95 | SGK3 | 0.65915754 |
| 96 | CDC42BPA | 0.65683707 |
| 97 | MAP3K8 | 0.65372029 |
| 98 | MAP3K3 | 0.65168987 |
| 99 | LIMK1 | 0.64603688 |
| 100 | MAP3K1 | 0.63638217 |
| 101 | PDK4 | 0.62830227 |
| 102 | PDK3 | 0.62830227 |
| 103 | MTOR | 0.62779753 |
| 104 | RPS6KA2 | 0.59831434 |
| 105 | OXSR1 | 0.59589938 |
| 106 | TNIK | 0.59570707 |
| 107 | NTRK1 | 0.59524719 |
| 108 | SGK223 | 0.58217536 |
| 109 | SGK494 | 0.58217536 |
| 110 | CAMKK2 | 0.58000447 |
| 111 | CDK8 | 0.57824239 |
| 112 | GSK3A | 0.56942640 |
| 113 | MET | 0.55596680 |
| 114 | GRK5 | 0.55565394 |
| 115 | JAK2 | 0.54903733 |
| 116 | CCNB1 | 0.54479784 |
| 117 | BMPR2 | 0.52106498 |
| 118 | RET | 0.51868437 |
| 119 | ERBB4 | 0.51825751 |
| 120 | PRKAA2 | 0.51386570 |
| 121 | TAOK3 | 0.51344761 |
| 122 | SGK1 | 0.50879203 |
| 123 | CDK6 | 0.49385442 |
| 124 | JAK1 | 0.49154665 |
| 125 | CDK5 | 0.49086874 |
| 126 | PRKACG | 0.48102101 |
| 127 | MAP2K6 | 0.47685358 |
| 128 | GRK6 | 0.47112547 |
| 129 | AURKA | 0.46465511 |
| 130 | MAP3K7 | 0.44673792 |
| 131 | RPS6KL1 | 0.44570798 |
| 132 | RPS6KC1 | 0.44570798 |
| 133 | STK38L | 0.44402510 |
| 134 | TAOK1 | 0.44289750 |
| 135 | RPS6KB1 | 0.43778132 |
| 136 | HIPK2 | 0.43739764 |
| 137 | MAPK12 | 0.43396831 |
| 138 | MAPK4 | 0.42841799 |
| 139 | PRKCH | 0.41767890 |
| 140 | WNK3 | 0.41551706 |
| 141 | CAMK2D | 0.41023632 |
| 142 | NEK1 | 0.40776837 |
| 143 | PBK | 0.40756659 |
| 144 | AKT2 | 0.40750062 |
| 145 | TTN | 0.40587343 |
| 146 | CAMK1 | 0.40575645 |
| 147 | KSR1 | 0.39733622 |
| 148 | LATS2 | 0.39122430 |
| 149 | TYK2 | 0.38365187 |
| 150 | RPS6KA4 | 0.37904570 |
| 151 | RAF1 | 0.36509771 |
| 152 | MAP4K1 | 0.36375430 |
| 153 | NEK6 | 0.35395932 |
| 154 | ARAF | 0.35226868 |
| 155 | PRKCI | 0.33861959 |
| 156 | FLT3 | 0.33149350 |
| 157 | ATR | 0.33052829 |
| 158 | RPS6KA3 | 0.32804785 |
| 159 | ILK | 0.31805853 |
| 160 | ZAP70 | 0.31373715 |
| 161 | CDK15 | 0.29186883 |
| 162 | EIF2AK1 | 0.28800181 |
| 163 | CDK11A | 0.27979865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.88019003 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.79345039 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98992332 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.65550457 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.65386279 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.56892390 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.50910076 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.35227963 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33163917 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24998056 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.15410839 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13999144 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.05987797 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05128787 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93815989 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.93583970 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92822994 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.87594139 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.86671773 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.85666467 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83825019 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.77817191 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.77003489 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61755648 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60813520 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56980475 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47046586 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46669824 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46162542 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.44164081 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39539262 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36520796 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35118968 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34161910 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34143840 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31746838 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29951245 |
| 38 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.26819326 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26652938 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26650062 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.24370363 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.23066667 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22265644 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21980437 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21261171 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.18233860 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16164353 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12916734 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.12009688 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12008387 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.08856806 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08260971 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06484875 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05234862 |
| 55 | DNA replication_Homo sapiens_hsa03030 | 1.02778466 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00177880 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99443872 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98904330 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98568767 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.96744142 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95500229 |
| 62 | Base excision repair_Homo sapiens_hsa03410 | 0.92129932 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91124967 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88004658 |
| 65 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87311971 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82419128 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80677669 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78591606 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76950565 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76807548 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76243027 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71649277 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67703631 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.62215665 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.59880869 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58470767 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55958319 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54620609 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53709348 |
| 80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.51601068 |
| 81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51484933 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50862066 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49863628 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46788616 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46301334 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.44578949 |
| 87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.43220360 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43121784 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42758480 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42713095 |
| 91 | Taste transduction_Homo sapiens_hsa04742 | 0.42132409 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.41591883 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.40939521 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39343515 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35572292 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34878817 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.34177921 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.32648579 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.32218365 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32088062 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32030458 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32018191 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31196622 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31047028 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.30030257 |
| 106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.25507993 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25366981 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24230530 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.23460776 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22176103 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22013395 |
| 112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21759195 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20927028 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.20110870 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19194082 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19102934 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.18274840 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.18237524 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17827035 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17469379 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.16238558 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14206994 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.14047432 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.13073084 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12149303 |
| 126 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.11237612 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10740378 |
| 128 | Mismatch repair_Homo sapiens_hsa03430 | 0.08174916 |
| 129 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.07936366 |
| 130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04941785 |

